2012
DOI: 10.1016/j.jinf.2012.06.008
|View full text |Cite
|
Sign up to set email alerts
|

Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
28
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(30 citation statements)
references
References 34 publications
2
28
0
Order By: Relevance
“…ϩϩ CD16 ϩ intermediate monocytes (10)(11)(12)46) and the plasma factors sCD14 (13,14,17,47) and sCD163 (15,16,40,48) as biomarkers of monocyte/macrophage activation and pathogenesis in SIV and HIV-1 disease. Therefore, we investigated the relationship between these variables and change in monocyte apoptosis with increasing viral load.…”
Section: Markers Of Innate Immune Activation Are Increased With Hivmentioning
confidence: 99%
“…ϩϩ CD16 ϩ intermediate monocytes (10)(11)(12)46) and the plasma factors sCD14 (13,14,17,47) and sCD163 (15,16,40,48) as biomarkers of monocyte/macrophage activation and pathogenesis in SIV and HIV-1 disease. Therefore, we investigated the relationship between these variables and change in monocyte apoptosis with increasing viral load.…”
Section: Markers Of Innate Immune Activation Are Increased With Hivmentioning
confidence: 99%
“…Whether this is mediated by HIV severity remains unknown. 32 Second, the increased lower lung and, therefore, diff use emphysema in individuals with HIV infection points to potential vascular-related pathways consistent with the fi nding that systemic levels of sCD14 are associated with emphysema severity. Because blood fl ow tends to be greater in basal and dependent lung segments, 40 endothelial dysfunction in the setting of chronic HIV-related immune activation may lead to greater lower lung involvement and diff use emphysema.…”
Section: Discussionmentioning
confidence: 63%
“…[28][29][30][31] Elevated sCD14 levels may refl ect greater immune activation as a result of mucosal bacterial translocation despite ART. 16,20,32 High sCD14 is associated with increased mortality 20 and neurocognitive impairment 33 among individuals with HIV infection. Elevated sCD14 levels have also been identifi ed in BAL fl uid of smokers in the general population 34 and in patients with ARDS, 35 supporting a potential link with lung disease.…”
Section: Discussionmentioning
confidence: 99%
“…This lack of association suggests that in this cohort, sCD14 does not specifically represent the construct of “microbial translocation,” but may represent non-specific monocyte activation, as discussed above. Although prior microbial translocation data have demonstrated that high levels of sCD14 in the plasma reflect LPS exposure[30], the two markers have not been reliably correlated in persons without significant immune suppression[90]; furthermore, in vivo work has shown IL-6 or IL-1β stimulation can induce sCD14 production comparable to that induced by LPS[91], suggesting inflammatory signaling independent of microbial translocation. Microbial translocation cannot be discounted as a factor in HIV-associated pulmonary disease based on this relatively small sample, but the contributions compared to other pathways appear to be limited.…”
Section: Discussionmentioning
confidence: 99%